Khorana Risk Score for Thrombosis Prediction in Patients with Gynecologic Malignancies Using Immune Checkpoint Inhibitors- a Real-World Validation

被引：0

作者：

Song, Junmin ^{[1
]}

Chang, Yu-Cheng ^{[2
]}

Abram, Ana Maria Diaz ^{[1
]}

Ahn, Jaeun ^{[3
]}

Chi, Kuan-Yu ^{[1
]}

Chang, Yu ^{[4
]}

Chiang, Cho-Han ^{[5
]}

机构：

[1] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Bronx, NY 10461 USA

[2] Danbury Hosp, Dept Med, Danbury, CT USA

[3] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA USA

[4] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg,Sect Neurosurg, Tainan, Taiwan

[5] Harvard Med Sch, Mt Auburn Hosp, Dept Med, Cambridge, MA USA

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-212175

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5582 / 5583

页数：2

共 50 条

[1] Real-World Validation of the Khorana Risk Score in Predicting Thrombosis for Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Song, Junmin
Chang, Yu-Cheng
Ahn, Jaeun
Chi, Kuan-Yu
Chang, Yu
Chiang, Cho-Han
BLOOD, 2024, 144 : 4020 - 4021
[2] Real-world validation of the Khorana risk score in gastric cancer patients receiving immune checkpoint inhibitors.
Song, Junmin
Li, Wing Fai
Yim, Chaeseong
Gong, Changlin
Chang, Yu-Cheng
Chang, Yu
Ahn, Jaeun
Chi, Kuan-Yu
Fahimuddin, Muhammad
Chiang, Cho Han
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 363 - 363
[3] Khorana risk score in lung cancer patients treated with immune checkpoint inhibitors: a real-world study
Song, Junmin
Morgan, Ahmed Ashraf
Abram, Ana Maria Diaz
Hong, Daniel
Kim, Gagi
Li, Wing Fai
Ahn, Jaeun
Chang, Yu
Chi, Kuan-Yu
Chiang, Cho-Han
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2025,
[4] The Khorana score and risk of venous thromboembolism in patients with cancer treated with immune checkpoint inhibitors
Overvad, T. F.
Ording, A. G.
Nielsen, P. B.
Piazza, G.
Noble, S.
Larsen, T. B.
Skjoth, F.
THROMBOSIS RESEARCH, 2022, 213 : S4 - S5
[5] Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data
Lippenszky, Levente
Mittendorf, Kathleen F.
Kiss, Zoltan
LeNoue-Newton, Michele L.
Napan-Molina, Pablo
Rahman, Protiva
Ye, Cheng
Laczi, Balazs
Csernai, Eszter
Jain, Neha M.
Holt, Marilyn E.
Maxwell, Christina N.
Ball, Madeleine
Ma, Yufang
Mitchell, Margaret B.
Johnson, Douglas B.
Smith, David S.
Park, Ben H.
Micheel, Christine M.
Fabbri, Daniel
Wolber, Jan
Osterman, Travis J.
JCO CLINICAL CANCER INFORMATICS, 2024, 8
[6] Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data
Lippenszky, Levente
Mittendorf, Kathleen F.
Kiss, Zoltan
LeNoue-Newton, Michele L.
Napan-Molina, Pablo
Rahman, Protiva
Ye, Cheng
Laczi, Balazs
Csernai, Eszter
Jain, Neha M.
Holt, Marilyn E.
Maxwell, Christina N.
Ball, Madeleine
Ma, Yufang
Mitchell, Margaret B.
Johnson, Douglas B.
Smith, David S.
Park, Ben H.
Micheel, Christine M.
Fabbri, Daniel
Wolber, Jan
Osterman, Travis J.
JCO CLINICAL CANCER INFORMATICS, 2024, 8
[7] The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study
Overvad, Thure F.
Skjoth, Flemming
Piazza, Gregory
Noble, Simon
Ording, Anne G.
Larsen, Torben B.
Nielsen, Peter B.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (12) : 2921 - 2929
[8] Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
Rupa-Matysek, Joanna
Gil, Lidia
Kazmierczak, Maciej
Baranska, Marta
Komarnicki, Mieczyslaw
MEDICAL ONCOLOGY, 2018, 35 (01)
[9] Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
Joanna Rupa-Matysek
Lidia Gil
Maciej Kaźmierczak
Marta Barańska
Mieczysław Komarnicki
Medical Oncology, 2018, 35
[10] Real-world data in the era of immune checkpoint inhibitors
Narita, Yukiya
ANNALS OF ONCOLOGY, 2021, 32 : S250 - S250

← 1 2 3 4 5 →